PATH
PATH is seeking an experienced clinical trial biostatistician to support the design, planning, execution, and analysis of Phase 1, 2, and 3 vaccine clinical trials, with an initial focus on oral polio vaccine studies. The role involves statistical leadership, oversight of external partners, and contributions to protocol design, analysis planning, and regulatory support. This position requires strong expertise in biostatistics, clinical trial methodology, and statistical software programming.
Headquarters
Seattle, Washington, United States
Company Size
1001-5000 employees
Founded
1977
We are a global team of innovators working to accelerate health equity so all people and communities can thrive.
Piper Sandler Sees Path to Growth for Bristol-Myers Squibb Company (BMY) After Eliquis Patent Expiry
18 hours ago
PATH Q4 Deep Dive: AI Expansion and Margin Progress Offset by Cautious Outlook
10 hours ago
3840.T Path Corporation up 21.05% pre-market on JPX 13 Mar 2026: heavy volume signals momentum
7 hours ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for PATH.
Right around the average for this role
Wells Fargo & Company Issues Pessimistic Forecast for UiPath (NYSE:PATH) Stock Price
11 hours ago